LienTeh.net > Ads > LuciErlo (Erlotinib)

LuciErlo (Erlotinib)

Inquire / Price

Model Number：

RL3120250101
Brand Name：

LuciErlo
Origin：

Generic drug，Laos
Small Orders：

Small batches also available
Tags：

EGFR+NSCLC NSCLC Lung Cancer

Inquire Now Link

Poster

Details
Description

Packaging Size

30t/bottle
Strength

150mg
Compositon

Erlotinib
Treatment

EGFR exon 19 deletions or exon 21 (L858R) substitution mutations non-small cell lung cancer (NSCLC)
Form

Tablet
Brand

LuciErlo
Quantity Unit

150mg*30T/bottle
Manufacturer

Lucius Pharmaceuticals (Lao) Co.,Ltd

INDICATIONS AND USAGE

Erlotinib is a kinase inhibitor indicated for:

· The treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving first-line, maintenance, or second or greater line treatment after progression following at least one prior chemotherapy regimen.

· First-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer, in combination with gemcitabine.

Limitations of Use:

· Safety and efficacy of LuciErlo have not been established in patients with NSCLC whose tumors have other EGFR mutations.

· LuciErlo is not recommended for use in combination with platinumbased chemotherapy.

DOSAGE AND ADMINISTRATION

· NSCLC: 150 mg orally, on an empty stomach, once daily.

· Pancreatic cancer: 100 mg orally, on an empty stomach, once daily.